These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11423662)

  • 41. Discovery of new MurA inhibitors using induced-fit simulation and docking.
    Rožman K; Lešnik S; Brus B; Hrast M; Sova M; Patin D; Barreteau H; Konc J; Janežič D; Gobec S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):944-949. PubMed ID: 28077258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MS2 Lysis of Escherichia coli Depends on Host Chaperone DnaJ.
    Chamakura KR; Tran JS; Young R
    J Bacteriol; 2017 Jun; 199(12):. PubMed ID: 28396351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure and function of the Mur enzymes: development of novel inhibitors.
    El Zoeiby A; Sanschagrin F; Levesque RC
    Mol Microbiol; 2003 Jan; 47(1):1-12. PubMed ID: 12492849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the loop containing residue 115 in the induced-fit mechanism of the bacterial cell wall biosynthetic enzyme MurA.
    Schönbrunn E; Eschenburg S; Krekel F; Luger K; Amrhein N
    Biochemistry; 2000 Mar; 39(9):2164-73. PubMed ID: 10694381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterocyclic electrophiles as new MurA inhibitors.
    Keeley A; Ábrányi-Balogh P; Hrast M; Imre T; Ilaš J; Gobec S; Keserű GM
    Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800184. PubMed ID: 30461051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Defective Undecaprenyl Pyrophosphate Synthase Induces Growth and Morphological Defects That Are Suppressed by Mutations in the Isoprenoid Pathway of Escherichia coli.
    MacCain WJ; Kannan S; Jameel DZ; Troutman JM; Young KD
    J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and functional characterization of phiX174 lysis protein E.
    Zheng Y; Struck DK; Young R
    Biochemistry; 2009 Jun; 48(22):4999-5006. PubMed ID: 19379010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. UDP-N-Acetylglucosamine enolpyruvyl transferase (MurA) of Acinetobacter baumannii (AbMurA): Structural and functional properties.
    Sonkar A; Shukla H; Shukla R; Kalita J; Pandey T; Tripathi T
    Int J Biol Macromol; 2017 Apr; 97():106-114. PubMed ID: 28064057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. UDP-N-acetylmuramic acid (UDP-MurNAc) is a potent inhibitor of MurA (enolpyruvyl-UDP-GlcNAc synthase).
    Mizyed S; Oddone A; Byczynski B; Hughes DW; Berti PJ
    Biochemistry; 2005 Mar; 44(10):4011-7. PubMed ID: 15751977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional consequence of covalent reaction of phosphoenolpyruvate with UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA).
    Zhu JY; Yang Y; Han H; Betzi S; Olesen SH; Marsilio F; Schönbrunn E
    J Biol Chem; 2012 Apr; 287(16):12657-67. PubMed ID: 22378791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.
    Ravishankar S; Kumar VP; Chandrakala B; Jha RK; Solapure SM; de Sousa SM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1410-8. PubMed ID: 15793120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors.
    Babajan B; Chaitanya M; Rajsekhar C; Gowsia D; Madhusudhana P; Naveen M; Chitta SK; Anuradha CM
    Interdiscip Sci; 2011 Sep; 3(3):204-16. PubMed ID: 21956743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystallization and preliminary X-ray crystallographic analysis of UDP-N-acetylglucosamine enolpyruvyl transferase from Haemophilus influenzae in complex with UDP-N-acetylglucosamine and fosfomycin.
    Yoon HJ; Ku MJ; Ahn HJ; Lee BI; Mikami B; Suh SW
    Mol Cells; 2005 Jun; 19(3):398-401. PubMed ID: 15995357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catalytic Mechanism and Covalent Inhibition of UDP-
    Mihalovits LM; Ferenczy GG; Keserű GM
    J Chem Inf Model; 2019 Dec; 59(12):5161-5173. PubMed ID: 31715096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sesquiterpene lactones are potent and irreversible inhibitors of the antibacterial target enzyme MurA.
    Bachelier A; Mayer R; Klein CD
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5605-9. PubMed ID: 16945528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
    Mendgen T; Scholz T; Klein CD
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5757-62. PubMed ID: 20729083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computed insight into a peptide inhibitor preventing the induced fit mechanism of MurA enzyme from Pseudomonas aeruginosa.
    Lima AH; Dos Santos AM; Alves CN; Lameira J
    Chem Biol Drug Des; 2017 Apr; 89(4):599-607. PubMed ID: 27736019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergism of mutations in bacteriophage Qbeta RNA affecting host factor dependence of Qbeta replicase.
    Schuppli D; Georgijevic J; Weber H
    J Mol Biol; 2000 Jan; 295(2):149-54. PubMed ID: 10623514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The fungal product terreic acid is a covalent inhibitor of the bacterial cell wall biosynthetic enzyme UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA) .
    Han H; Yang Y; Olesen SH; Becker A; Betzi S; Schönbrunn E
    Biochemistry; 2010 May; 49(19):4276-82. PubMed ID: 20392080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin.
    Olesen SH; Ingles DJ; Yang Y; Schönbrunn E
    J Basic Microbiol; 2014 Apr; 54(4):322-6. PubMed ID: 23686727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.